Literature DB >> 22895006

Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*.

Carl O Eriksson1, Dionne A Graham, Timothy M Uyeki, Adrienne G Randolph.   

Abstract

OBJECTIVE: We tested the hypothesis that the use of mechanical ventilator support in children hospitalized with influenza during the 2009 H1N1 influenza A (H1N1) pandemic was higher than would be expected in children hospitalized for seasonal influenza after adjusting for patient risk.
DESIGN: Retrospective cohort study.
SETTING: Forty-three U.S. pediatric hospitals. PATIENTS: Children <18 yrs old with a discharge diagnosis of influenza admitted July 2006 through March 2009 (seasonal influenza) and June through December 2009 (2009 pandemic influenza A).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We included 10,173 children hospitalized with seasonal influenza and 9837 with presumed 2009 pandemic influenza A. The 2009 pandemic influenza A cohort was older (median 5.0 vs. 1.9 yrs), more likely to have asthma (30% vs. 18%), and less likely to receive mechanical ventilation (7.1% [n = 701] vs. 9.2% [n = 940]). Using logistic regression, we created a multivariable model of risk factors associated with endotracheal mechanical ventilator support in the seasonal influenza cohort and used this model to predict the number of expected mechanical ventilation cases in children with presumed 2009 pandemic influenza A. Adjusted for underlying health conditions, race, age, and a co-diagnosis of bacterial pneumonia, the observed/expected rate of mechanical ventilation in the presumed 2009 pandemic influenza A cohort was 0.74 (95% confidence interval 0.68-0.79). Early hospital treatment with influenza antiviral medications was associated with decreased initiation of mechanical ventilation on hospital day ≥ 3 in the seasonal influenza (odds ratio 0.66; 95% confidence interval 0.45-0.97) and 2009 pandemic influenza A (odds ratio 0.23; 95% confidence interval 0.16-0.34) periods; influenza antiviral use in the 2009 pandemic influenza A period was much higher (70% vs. 20%; p < .001).
CONCLUSIONS: Although the number of children with a hospital discharge diagnosis of influenza almost tripled during the 2009 pandemic influenza A period, the risk-adjusted proportion of children receiving mechanical ventilation was lower than we would have predicted in a seasonal influenza cohort. Early hospital use of influenza antiviral medications was associated with a decrease in late-onset mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895006      PMCID: PMC6615726          DOI: 10.1097/PCC.0b013e318260114e

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  37 in total

1.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

2.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

3.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

Authors:  K M Neuzil; B G Mellen; P F Wright; E F Mitchel; M R Griffin
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

4.  Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004.

Authors:  Stephanie J Schrag; David K Shay; Ken Gershman; Ann Thomas; Allen S Craig; William Schaffner; Lee H Harrison; Duc Vugia; Paula Clogher; Ruth Lynfield; Monica Farley; Shelley Zansky; Timothy Uyeki
Journal:  Pediatr Infect Dis J       Date:  2006-05       Impact factor: 2.129

5.  Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza.

Authors:  Susan E Coffin; Theoklis E Zaoutis; Anna B Wheeler Rosenquist; Kateri Heydon; Guillermo Herrera; Carolyn B Bridges; Barbara Watson; Russell Localio; Richard L Hodinka; Ron Keren
Journal:  Pediatrics       Date:  2007-04       Impact factor: 7.124

6.  The burden of influenza illness in children with asthma and other chronic medical conditions.

Authors:  K M Neuzil; P F Wright; E F Mitchel; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

7.  Influenza-associated deaths among children in the United States, 2003-2004.

Authors:  Niranjan Bhat; Jennifer G Wright; Karen R Broder; Erin L Murray; Michael E Greenberg; Maleeka J Glover; Anna M Likos; Drew L Posey; Alexander Klimov; Stephen E Lindstrom; Amanda Balish; Marie-jo Medina; Teresa R Wallis; Jeannette Guarner; Christopher D Paddock; Wun-Ju Shieh; Sherif R Zaki; James J Sejvar; David K Shay; Scott A Harper; Nancy J Cox; Keiji Fukuda; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

8.  Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection.

Authors:  Ron Keren; Theoklis E Zaoutis; Carolyn B Bridges; Guillermo Herrera; Barbara M Watson; Anna B Wheeler; Daniel J Licht; Xian Qun Luan; Susan E Coffin
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

9.  A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.

Authors:  Michael K Gould; Lakshmi Ananth; Paul G Barnett
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

10.  Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.

Authors:  Jeffrey C Hageman; Timothy M Uyeki; John S Francis; Daniel B Jernigan; J Gary Wheeler; Carolyn B Bridges; Stephen J Barenkamp; Dawn M Sievert; Arjun Srinivasan; Meg C Doherty; Linda K McDougal; George E Killgore; Uri A Lopatin; Rebecca Coffman; J Kathryn MacDonald; Sigrid K McAllister; Gregory E Fosheim; Jean B Patel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  19 in total

1.  Influenza vaccination in children with neurologic or neurodevelopmental disorders.

Authors:  Michael Smith; Georgina Peacock; Timothy M Uyeki; Cynthia Moore
Journal:  Vaccine       Date:  2015-03-30       Impact factor: 3.641

2.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

3.  Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020.

Authors:  Patrick S Walsh; David Schnadower; Yin Zhang; Sriram Ramgopal; Samir S Shah; Paria M Wilson
Journal:  JAMA Pediatr       Date:  2022-09-19       Impact factor: 26.796

4.  Influenza-associated pediatric deaths in the United States, 2004-2012.

Authors:  Karen K Wong; Seema Jain; Lenee Blanton; Rosaline Dhara; Lynnette Brammer; Alicia M Fry; Lyn Finelli
Journal:  Pediatrics       Date:  2013-10-28       Impact factor: 7.124

5.  Estimates of the demand for mechanical ventilation in the United States during an influenza pandemic.

Authors:  Martin I Meltzer; Anita Patel; Adebola Ajao; Scott V Nystrom; Lisa M Koonin
Journal:  Clin Infect Dis       Date:  2015-05-01       Impact factor: 9.079

6.  Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children.

Authors:  James W Antoon; Matt Hall; Alison Herndon; David P Johnson; Charlotte M Brown; Whitney L Browning; Todd A Florin; Leigh M Howard; Carlos G Grijalva; Derek J Williams
Journal:  J Pediatr       Date:  2021-07-01       Impact factor: 4.406

Review 7.  What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?

Authors:  Andrew T Pavia
Journal:  Infect Dis Clin North Am       Date:  2012-12-12       Impact factor: 5.982

8.  Assessing the Capacity of the US Health Care System to Use Additional Mechanical Ventilators During a Large-Scale Public Health Emergency.

Authors:  Adebola Ajao; Scott V Nystrom; Lisa M Koonin; Anita Patel; David R Howell; Prasith Baccam; Tim Lant; Eileen Malatino; Margaret Chamberlin; Martin I Meltzer
Journal:  Disaster Med Public Health Prep       Date:  2015-10-09       Impact factor: 1.385

9.  The immune profile associated with acute allergic asthma accelerates clearance of influenza virus.

Authors:  Amali E Samarasinghe; Stacie N Woolard; Kelli L Boyd; Scott A Hoselton; Jane M Schuh; Jonathan A McCullers
Journal:  Immunol Cell Biol       Date:  2014-01-28       Impact factor: 5.126

10.  Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.

Authors:  Stella G Muthuri; Sudhir Venkatesan; Puja R Myles; Jo Leonardi-Bee; Wei Shen Lim; Abdullah Al Mamun; Ashish P Anovadiya; Wildo N Araújo; Eduardo Azziz-Baumgartner; Clarisa Báez; Carlos Bantar; Mazen M Barhoush; Matteo Bassetti; Bojana Beovic; Roland Bingisser; Isabelle Bonmarin; Victor H Borja-Aburto; Bin Cao; Jordi Carratala; María R Cuezzo; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Marcela Echavarria; Sergio Fanella; James Fraser; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath L Higuera Iglesias; Peter H Hoeger; Matthias Hoffmann; Xiaoyun Hu; Quazi T Islam; Mirela F Jiménez; Amr Kandeel; Gerben Keijzers; Hossein Khalili; Gulam Khandaker; Marian Knight; Gabriela Kusznierz; Ilija Kuzman; Arthur M C Kwan; Idriss Lahlou Amine; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Rita Linko; Pei Liu; Faris Madanat; Toshie Manabe; Elga Mayo-Montero; Allison McGeer; Ziad A Memish; Gokhan Metan; Dragan Mikić; Kristin G I Mohn; Ahmadreza Moradi; Pagbajabyn Nymadawa; Bulent Ozbay; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Wolfgang Poeppl; Fernando P Polack; Barbara A Rath; Alejandro H Rodríguez; Marilda M Siqueira; Joanna Skręt-Magierło; Ewa Talarek; Julian W Tang; Antoni Torres; Selda H Törün; Dat Tran; Timothy M Uyeki; Annelies van Zwol; Wendy Vaudry; Daiva Velyvyte; Tjasa Vidmar; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2016-02-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.